The category of compounds known as MMP-1a inhibitors encompasses a diverse group of chemical agents that have been identified and explored for their capacity to modulate the activity of the MMP-1a enzyme. MMP-1a, also known as collagenase-1, plays a crucial role in degrading components of the extracellular matrix, a pivotal process in tissue remodeling and various physiological contexts. MMP-1a inhibitors are designed to interact with specific molecular components of the enzyme's active site or associated pathways to impede its proteolytic activity. Chemically, MMP-1a inhibitors span a range of structural classes, including synthetic small molecules and naturally occurring compounds. These inhibitors exhibit a variety of molecular architectures, but their common objective is to hinder MMP-1a's capability to break down collagen and other extracellular matrix components. The mechanisms of action behind MMP-1a inhibition can vary significantly, depending on the inhibitor's mode of binding, its influence on catalytic sites, or its interference with enzyme-substrate interactions. Some MMP-1a inhibitors employ a "lock and key" approach, where they fit into the enzyme's active site and disrupt its catalytic function. Others may act allosterically, altering the enzyme's conformation and reducing its activity. Alternatively, inhibitors might target pathways that regulate MMP-1a expression or activation, attenuating its abundance and impact on the extracellular matrix.
The study of MMP-1a inhibitors is characterized by a meticulous exploration of structure-activity relationships, where researchers dissect the key structural elements that render a compound an effective inhibitor. This knowledge guides the refinement and design of compounds with enhanced inhibitory potency and specificity. Exploring MMP-1a inhibitors offers insights into the intricacies of extracellular matrix dynamics, tissue remodeling, and related processes. By understanding how these inhibitors influence MMP-1a activity, researchers can unravel fundamental biological mechanisms. The resulting knowledge aids in the comprehension of cellular responses to matrix remodeling and how this regulation may be perturbed in various disease states.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
GM 6001 (Ilomastat) is a synthetic compound that inhibits various matrix metalloproteinases, including MMP-1a. It has been studied for its potential to suppress extracellular matrix degradation and could have applications in tissue repair. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Marimastat is another synthetic compound that inhibits MMPs, including MMP-1a. It was investigated for its potential in cancer due to its ability to suppress metastasis-related processes. | ||||||
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
Batimastat is a synthetic inhibitor that targets MMPs, including MMP-1a. Similar to other MMP inhibitors, it has been explored for its potential in cancer and tissue repair. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a natural compound found in grapes and red wine, has been investigated for its inhibitory effects on MMP-1a activity. It might have implications for aging-related tissue remodeling. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, found in turmeric, has been studied for its potential to inhibit MMP-1a and other MMPs. It may influence extracellular matrix turnover and related processes. | ||||||